Free Trial

Anteris Technologies Global (NASDAQ:AVR) Issues Earnings Results

Anteris Technologies Global logo with Medical background

Key Points

  • Anteris Technologies Global reported an earnings per share (EPS) of ($0.58) for the quarter, missing analysts' estimates by ($0.05).
  • The company’s stock traded down $0.12 on Monday, reaching $3.50 per share, with an average trading volume of 75,834 shares.
  • Geode Capital Management LLC significantly raised its position in Anteris Technologies by 154.3% during the second quarter, owning 420,427 shares valued at approximately $1.59 million.
  • Looking to export and analyze Anteris Technologies Global data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Anteris Technologies Global (NASDAQ:AVR - Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.58) EPS for the quarter, missing analysts' consensus estimates of ($0.53) by ($0.05), Zacks reports.

Anteris Technologies Global Stock Performance

NASDAQ:AVR traded down $0.12 during trading hours on Monday, hitting $3.50. The company's stock had a trading volume of 75,834 shares, compared to its average volume of 155,201. The stock has a fifty day simple moving average of $3.77 and a 200-day simple moving average of $4.73. Anteris Technologies Global has a twelve month low of $2.34 and a twelve month high of $8.79.

Institutional Trading of Anteris Technologies Global

An institutional investor recently raised its position in Anteris Technologies Global stock. Geode Capital Management LLC raised its position in Anteris Technologies Global Corp. (NASDAQ:AVR - Free Report) by 154.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 420,427 shares of the company's stock after purchasing an additional 255,088 shares during the quarter. Geode Capital Management LLC owned 1.17% of Anteris Technologies Global worth $1,593,000 as of its most recent SEC filing.

Anteris Technologies Global Company Profile

(Get Free Report)

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Anteris Technologies Global Right Now?

Before you consider Anteris Technologies Global, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anteris Technologies Global wasn't on the list.

While Anteris Technologies Global currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Growth Stock Winners to Watch And 3 to Avoid
3 Growth Stocks That Could Pop Before Summer Ends
3 Buy-the-Dip Stocks Poised to Rebound Soon

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines